These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 19597194)
1. Creating access to health technologies in poor countries. Frost LJ; Reich MR Health Aff (Millwood); 2009; 28(4):962-73. PubMed ID: 19597194 [TBL] [Abstract][Full Text] [Related]
2. Poverty and access to health care in developing countries. Peters DH; Garg A; Bloom G; Walker DG; Brieger WR; Rahman MH Ann N Y Acad Sci; 2008; 1136():161-71. PubMed ID: 17954679 [TBL] [Abstract][Full Text] [Related]
3. Technical fixes and other problems in saving lives in the world's poorest countries. Reich MR J Public Health Policy; 1988; 9(1):92-103. PubMed ID: 3360918 [TBL] [Abstract][Full Text] [Related]
4. Patent law--balancing profit maximization and public access to technology. Beckerman-Rodau A Columbia Sci Technol Law Rev; 2003; 4():E1. PubMed ID: 15977333 [TBL] [Abstract][Full Text] [Related]
5. SatelLife: pioneering the path for electronic communication and health information in the developing world. Mullaney J Clin Perform Qual Health Care; 1997; 5(1):38-44. PubMed ID: 10164998 [TBL] [Abstract][Full Text] [Related]
6. Information and communication technologies and health in low income countries: the potential and the constraints. Chandrasekhar CP; Ghosh J Bull World Health Organ; 2001; 79(9):850-5. PubMed ID: 11584733 [TBL] [Abstract][Full Text] [Related]
7. Technologies for clinically relevant physiological measurements in developing countries. Malkin RA Physiol Meas; 2007 Aug; 28(8):R57-63. PubMed ID: 17664669 [TBL] [Abstract][Full Text] [Related]
8. The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries. Jadhav S; Datla M; Kreeftenberg H; Hendriks J Vaccine; 2008 Mar; 26(13):1611-5. PubMed ID: 18294742 [TBL] [Abstract][Full Text] [Related]
9. Response of health systems to urbanization in developing countries. Tabibzadeh I; Liisberg E World Health Forum; 1997; 18(3-4):287-93. PubMed ID: 9478144 [TBL] [Abstract][Full Text] [Related]
10. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development. Wallner PE; Konski A J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812 [TBL] [Abstract][Full Text] [Related]
12. Access as a policy-relevant concept in low- and middle-income countries. McIntyre D; Thiede M; Birch S Health Econ Policy Law; 2009 Apr; 4(Pt 2):179-93. PubMed ID: 19187569 [TBL] [Abstract][Full Text] [Related]
13. Providing affordable essential medicines to African households: the missing policies and institutions for price containment. Tetteh Ek Soc Sci Med; 2008 Feb; 66(3):569-81. PubMed ID: 18023953 [TBL] [Abstract][Full Text] [Related]
15. Clinics: Norplant cost chokes services. Family Plan World; 1993; 3(5):1, 28. PubMed ID: 12319135 [TBL] [Abstract][Full Text] [Related]
16. Globalization and perinatal medicine--how do we respond? Kurjak A; Di Renzo GC; Stanojevic M J Matern Fetal Neonatal Med; 2010 Apr; 23(4):286-96. PubMed ID: 19895359 [TBL] [Abstract][Full Text] [Related]
17. Sustainable transfer of biotechnology to developing countries: fighting poverty by bringing scientific tools to developing-country partners. Coloma J; Harris E Ann N Y Acad Sci; 2008; 1136():358-68. PubMed ID: 17954678 [TBL] [Abstract][Full Text] [Related]
18. Looking beyond the issue of access to insulin: what is needed for proper diabetes care in resource poor settings. Beran D; Yudkin JS Diabetes Res Clin Pract; 2010 Jun; 88(3):217-21. PubMed ID: 20447710 [TBL] [Abstract][Full Text] [Related]